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Abstract
Background: Although anemia is one of the leading causes of the global burden of disease, information about its
prevalence in Russia is mostly missing. We therefore assessed its prevalence and associated factors in a Russian
population.
Methods: The population-based Ural Eye and Medical Study included 5899 (80.5%) out of 7328 eligible individuals
(mean age:59.0 ± 10.7 years;range:40–94 years) who underwent a standardized interview and detailed general
examination. The definition of anemia was based on the hemoglobin concentration (definition #1:hemoglobin
concentration < 140 g/L in men,< 130 g/L in women; definition #2:hemoglobin concentration < 130 g/L in men,<
120 g/L in women [World Health Organization definition]).
Results: Higher hemoglobin concentration (mean:142.6 ± 14.8 g/L; range:80-171 g/L) was associated (multivariable
analysis) with male gender (P < 0.001; standardized regression coefficient beta:-0.20), higher waist-hip circumference
ratio (P < 0.001;beta:0.05), higher prevalence of car ownership (P < 0.001;beta:0.05), higher blood concentrations of
bilirubin (P < 0.001;beta:0.05) and triglycerides (P < 0.001;beta:0.06), lower erythrocyte sedimentation rate (P < 0.001;
beta:-0.32), and shorter blood clotting time (P < 0.001;beta:-0.39). Using definition #1 and #2, anemia was detected
in 1385 individuals (23.6%;95% confidence interval CI)CI:22.5,24.7) and in 453 individuals (7.7%;95%CI:7.0,8.4),
respectively. Prevalence of moderate anemia (hemoglobin concenttration:110 g/L-80 g/L), detected in 165
individuals (2.8%;95%CI:2.4,3.2), increased with younger age (P = 0.008;odds ratio (OR):0.98;95%CI:0.96,0.99), female
gender (P < 0.001;OR:2.52;95%CI:1.47,4.33), higher erythrocyte sedimentation rate (P < 0.001;OR:1.08;95%CI:1.06,1.09),
longer blood clotting time (P < 0.001;OR:8.56;95%CI:5.68,12.9), and marginally significantly, with a lower waist-hip
circumference ratio (P = 0.058;OR:0.13;95%CI:0.02,1.07). In women, it was significantly (P < 0.001) higher before
menopause (8.8%;95%CI:6.4,11.1) than after menopause (3.5%;95%CI:2.8,4.3).
Conclusions: In this Russian population as compared to populations from countries with a similar socio-
demographic index, anemia prevalence was relatively low. As in other populations, higher anemia prevalence was
strongly and inversely associated with menopause, and to a minor degree, with lower waist-hip circumference ratio
and lower socio-economic background.
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Background
The Global Burden of Diseases, Injuries and Risk Factors
(GBD) Study estimated in 2010 that the global preva-
lence of anemia was 32.9%, and that anemia caused 68.4
million YLDs (years lived with disability) or 8.8% of all
YLDs [1, 2]. That figure was higher than the figures for
major depression (63.2 million YLD; 8.2%), chronic re-
spiratory diseases (49.3 million YLDs, 6.3%) and the
whole of all injuries (47.2 million YLDs; 6.3%). The
anemia-associated YLDs increased in all ages between
1990 and 2010, driven by a combination of increased
prevalence and population growth in the young age
groups. In adulthood, the increase in the anemia-related
YLDs was attributed to population growth and enhanced
survival of chronic diseases associated with anemia, such
as chronic kidney disease. In elderly groups, the increase
in the anemia-associated YLDs was mainly due to popu-
lation aging while the anemia prevalence in the elderly
age groups decreased from all causes except for malaria.
In most regions and age groups, anemia prevalence was
higher in females than in males [1–3].
Despite the general importance of anemia for public
health and although Russia is by area the largest, and by
population one of the most populous countries world-
wide, information about the prevalence of anemia in
Russia and factors associated with the occurrence of
anemia in Russia has been mostly missing so far. We
therefore conducted this study to assess the prevalence
of anemia in a population in Russia and to explore its
associations with other factors [4, 5].
Methods
Designed as a population-based investigation, the Ural
Eye and Medical Study (UEMS) was carried out in the
Ufa (urban region of Kirovskii), the capital of the Rus-
sian Republic of Bashkortostan, and in villages of the
Karmaskalinsky District located in a distance of 65 km
from Ufa [6]. Bashkortostan (total population: 4.07 mil-
lion) is located in the west of the southern Ural Moun-
tains. The population of Ufa with 1.1 million inhabitants
includes Russians, Tatars, Bashkirs, Ukrainians and other
ethnicities. While there were no exclusion criteria, the
only inclusion criteria for the participation in the study
were an age of 40 or more years and living in the study
region.
The series of examinations started with a standardized
interview which was performed by trained social
workers. It consisted of more than 250 questions about
socioeconomic variables (e.g., educational level), life style
including diet, smoking and alcohol consumption, de-
pression and suicidal ideation, physical activity, and
medical history including known diagnosis and therapy
of major systemic diseases including presence or history
of previous iron-deficiency related anemia. The data
were reported using the Guidelines for Accurate and
Transparent Health Estimates Reporting: the GATHER
statement guidelines [7].
The physical examinations included measurement of
blood pressure, pulse rate and body height, body weight
and hip and waist circumference. Using a dynamometer,
we determined the handgrip strength. We measured
hearing loss by hearing loss-related questions in the
interview and by conducting Rinne’s test and Weber’s
test. The assessment of blood samples, which were taken
under fasting conditions, included a complete blood cell
count and determinations of the serum concentrations
of glucose, blood lipids, C-reactive protein, bilirubin,
urea, creatinine, and other substances. The pulmonary
function was tested by spirometry. Diabetes mellitus was
defined by a glucose concentration of ≥7.0 mmol/L or a
self-reported history of a physician-related diagnosis of
diabetes or a history of drug treatment of diabetes. Using
the Center for Epidemiologic Studies Depression Scale
(CES-D) Scoresheet, we assessed the presence of depres-
sion. We applied the State-Trait Anxiety Inventory
(STAI) to determine trait and state anxiety.
Anemia was defined by a hemoglobin concentration of
less than 140 g/L in men and of less than 130 g/L in
women (definition #1), and it was defined by a
hemoglobin concentration of less than 130 g/L in men
and of less than 120 g/L in women (definition #2). The
reason to use two definitions of anemia was that anemia
has not yet been generally defined in a consensus meet-
ing or corresponding article. While the second anemia
definition applied in our study accorded with the WHO
(World Health Organization) definition of anemia, the
first definition was based on the several previous
population-based studies which addressed the preva-
lence of anemia and which used different definitions of
anemia [1–5, 8, 9]. Anemia was classified into mild
anemia (definition #1: hemoglobin concentration of 139
g/L to 110 g/L in men and of 129 g/L to 110 g/L in
women; and definition #2: hemoglobin concentration of
129 g/L to 110 g/L in men and of 119 g/L to 110 g/L in
women), and into moderate anemia (both definitions #1
and #2) with a hemoglobin concentration ranging be-
tween less than 110 g/L and 80 g/L in both gender. Se-
vere anemia was defined by a hemoglobin concentration
of less than 80 g/L.
We used a commercially available statistical software
program (Statistical Package for Social Science, SPSS,
version 25.0; IBM-SPSS Inc., Chicago, USA) for the stat-
istical analysis. In a first step, we determined the mean
hemoglobin concentration, expressed as mean ± stand-
ard deviation, and the mean prevalence of anemia, pre-
sented as mean and its 95% confidence intervals (CI). In
a second step, we searched for associations in univariate
analysis between the prevalence of anemia and other
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parameters. In a third step, we conducted a multivariable
binary regression analysis with the prevalence of anemia
as dependent variable and as independent variables all
those parameters which were significantly associated
with the prevalence of anemia in the univariate analysis.
Finally, we assessed associations between the blood
hemoglobin concentration and other parameters in a
multivariable linear regression analysis. Odds ratios (OR)
and their 95% CIs, the standardized regression coeffi-
cient beta and the non-standardized regression coeffi-
cient B were calculated. All P-values were two-sided and
considered statistically significant when the values were
less than 0.05.
Results
Out of 5889 individuals primarily participating in the
Ural Eye and Medical Study, the present study included
5864 (99.4%) individuals with biochemical blood exami-
nations. The mean age of the study population (2559
(43.6%) men) was 59.0 ± 10.7 years (Table 1). The com-
position of the study population with respect to gender
and age corresponded to the gender and age distribution
in the Russian population according to the most recent
census carried out in 2010 [9]. It showed two constric-
tions for the birth year groups from 1940 to 1946 and
for the birth year groups from 1962 to 1970, directly and
indirectly caused by the consequences of World War II.
The group of individuals with information about the
hemoglobin concentration and the group of subjects
without blood examination data did not differ signifi-
cantly in age (59.0 ± 10.7 years versus 61.1 ± 12.9 years;
P = 0.33), gender (2259 (43.6%) men / 3305 (56.4%)
women versus 21 (60.0%) men / 14 (40.0%) women; P =
0.06), and level of education (P = 0.98).
The mean hemoglobin concentration was 142.6 ± 14.8
g/L (median: 144 g/L; range: 80–171 g/L) (Fig. 1). It was
significantly higher in men than in women (150.4 ± 12.6
g/L versus 136.6 ± 13.6 g/L; P < 0.001). Applying defin-
ition #1, anemia as a whole was detected in 1385 indi-
viduals (23.6%; 95%CI: 22.5, 24.7), and mild anemia was
present in 1220 individuals (20.8%; 95%CI: 19.8, 21.8).
The age-standardized prevalence rates based on the
WHO world standard population aged 40+ years were
23,5% for anemia as a whole (definition #1) and 20,2%
for mild anemia (definition #1). Using definition #2,
anemia as a whole was found in 453 individuals (7.7%;
95%CI: 7.0, 8.4), and mild anemia was present in 288 in-
dividuals (4.9%; 95%CI: 4.4, 5.5). The age-standardized
prevalence rates based on the WHO world standard
population aged 40+ years were 8.2% for anemia as a
whole (definition #2) and 5.1% for mild anemia (defin-
ition #2). Among the 288 individuals with mild anemia,
35 (12.2%) participants reported about the presence of
an iron-deficiency anemia. Moderate anemia (both
definitions #1 and #2) was diagnosed for 165 individuals
(2.8%; 95%CI: 2.4, 3.2), out of whom 38 (23%) partici-
pants reported about the presence of an iron-deficiency
anemia. The age-standardized prevalence rate for mod-
erate anemia as based on the WHO world standard
population aged 40+ years was 3.2%. None of study par-
ticipants had severe anemia.
Within the Russian group (n = 1182; 506 (42.8%) men)
with a mean age of 60.1 ± 11.1 years, the prevalence of
anemia (definition #1) as a whole was 266 / 1182 (22.5%;
95%CI: 20.1, 24.9), the prevalence of mild anemia (defin-
ition #1) was 230 / 1182 (19.5%; 95%CI: 17.2, 21.7), and
the prevalence of moderate anemia was (36 / 1182; 3.0%;
95%CI: 2.1, 4.0) (Table 2). Applying the anemia defin-
ition #2, the anemia prevalence as a whole was 79 /
1182 (6.7%; 95%CI: 5.3, 8.1), and the prevalence of mild
anemia was 43 / 1182 (3.6%; 95%CI: 2.6, 4.7). The preva-
lences of anemia as a whole (definition #1), of mild
anemia (definition #1) and moderate anemia did not dif-
fer significantly between the Russian group and the non-
Russian group (P = 0.44, P = 0.27, and P = 0.55, respect-
ively). In a similar manner, the prevalence of anemia as a
whole (definition #2) and of mild anemia (definition #2)
did not vary significantly between the Russian group and
the non-Russian group (P = 0.26 and P = 0.052, resp.).
As a corollary, the hemoglobin concentration did not
vary significantly (P = 0.06; beta: 0.02) between both eth-
nic groups after adjusting for gender.
In univariate analysis, a higher prevalence of anemia
(definition #1) was associated with older age (P < 0.001)
and female gender (P < 0.001) (Fig. 2). For exploring any
other associations, we adjusted the analysis for age and
gender. After adjusting for age and gender, a higher
prevalence of anemia was associated with lower preva-
lence of married family status (P = 0.01), higher preva-
lence of Muslima religion (P = 0.07), lower body weight
(P < 0.001) and lower body mass index (P < 0.001),
shorter waist circumference (P < 0.001), shorter hip cir-
cumference (P = 0.001), and lower waist-to-hip circum-
ference ratio (P < 0.001), lower monthly income (P =
0.04), lower frequency of an ownership of a car (P =
0.001), lower prevalence of a history of arterial hyperten-
sion (P = 0.002), tumbling (P = 0.08) and menopause
(P < 0.001), higher prevalence of a history of iron-
deficiency anemia (P < 0.001), lower blood concentration
of alanine transferase (P = 0.003), aspartate aminotrans-
ferase (P = 0.02), bilirubin (P < 0.001), low-density lipo-
proteins (P = 0.02), triglycerides (P < 0.001), cholesterol
(P < 0.001), higher blood concentration of the rheuma-
toid factor (P = 0.001), creatinine (P = 0.001), urea (P =
0.001), residual nitrogen (P = 0.09), faster erythrocyte
sedimentation rate (P < 0.001), longer blood clotting
time (P < 0.001), lower prothrombin time (P = 0.05),
lower blood count of leukocytes (P < 0.001), any type of
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granulocytes (P < 0.001), lymphocytes and monocytes
(P < 0.001), lower systolic (P = 0.01) and diastolic (P <
0.001) blood pressure, higher ankle-brachial index (P =
0.07), higher prevalence of not able to stop drinking al-
cohol once started (P = 0.003), of failing to do what was
normally expected due to alcohol consumption (P =
0.02) and of feeling guilty after drinking (P = 0.01),
higher total hearing loss score (P = 0.02), and lower
manual dynamometric force (P < 0.001) (Table 3).
The multivariable regression analysis included the
prevalence of anemia (definition #1) as dependent vari-
able and as independent variables all those parameters
which were significantly associated with the prevalence
of anemia in the univariate analysis. Due to collinearity
we first dropped the parameters of body weight, and hip
and waist circumference. Due to a lack of statistical sig-
nificance, we dropped the parameters of alcohol
consumption-related parameters (“feeling guilty after
drinking alcohol” (P=0.73); “failing to do what was nor-
mally expected due to alcohol consumption” (P = 0.89);
“not able to stop drinking alcohol once started” (P =
0.10)), religion (P = 0.97), blood concentrations of
rheumatoid factor (P = 0.99), low-density lipoproteins
(P = 0.79), urea (P = 0.83), alanine transferase (P = 0.95),
aspartate aminotransferase (P = 0.39), creatinine (P =
0.45) and prothrombin time (P = 0.49), family status
(married versus non-married) (P = 0.43), history of tum-
bling (P = 0.78) and arterial hypertension (P = 0.58),
manual dynamometric force (P = 0.42), count of lym-
phocytes (P = 0.21) and monocytes (P = 0.24), ankle-
brachial index (P = 0.34), systolic blood pressure (P =
0.30), body mass index (P = 0.28), self-reported income
(P = 0.19), blood residual nitrogen (P = 0.16), hearing
loss score (P = 0.17), blood concentration of cholesterol
(P = 0.11), diastolic blood pressure (P = 0.08) and age
(P = 0.33). In the final model, a higher prevalence of
anemia (definition #1) was associated with male gender
(P < 0.001), lower waist-hip circumference ratio (P =
0.002), lower prevalence of an ownership of a car (P =
0.005), lower blood concentrations of bilirubin (P <
0.001) and triglycerides (P = 0.003), higher erythrocyte
sedimentation rate (P < 0.001), longer blood clotting
time (P < 0.001) and lower count of leukocytes (P = 0.03)
(Table 4). If the parameter of car ownership was re-
placed by the parameter of level of education, lower edu-
cational level was significantly associated with higher
anemia prevalence (P = 0.001; OR: 0.93; 95%CI: 0.89,
0.97). There was a tendency for higher anemia preva-
lence in the urban versus rural region of habitation (P =
0.10; OR: 0.84; 95%CI: 0.68, 1.03).
In a similar manner, a higher prevalence of anemia as
defined by definition #2 was associated with male gender
(P < 0.001), lower waist-hip circumference ratio (P =
0.01), lower prevalence of an ownership of a car (P =
0.006), lower blood concentrations of bilirubin (P =
0.006) and triglycerides (P = 0.003), higher erythrocyte
sedimentation rate (P < 0.001), longer blood clotting
time (P < 0.001) and lower count of leukocytes (P =
0.03), and additionally with younger age (P = 0.045)
(Table 5). In women, it was significantly higher before
menopause (16.6%; 95%CI: 13.5, 19.7) than after meno-
pause (7.1%; 95%CI: 6.0, 8.1).
Higher prevalence of moderate anemia was correlated
with younger age (P = 0.008), female gender (P < 0.001),
higher erythrocyte sedimentation rate (P < 0.001), longer
blood clotting time (P < 0.001), and marginally
Fig. 1 Histogram showing the distribution of the blood hemoglobin concentration stratified by gender in the Ural Eye and Medical Study
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Table 2 Associations of the prevalence of anemia (defined as a hemoglobin concentration < 140 g/ in men and < 130 g/L in
women) in the Ural Eye and Medical Study, after adjusting for gender and age
Parameter P-Value Odds Ratio 95% Confidence Intervals
Urban / rural region of habitation 0.38
Family status: Married / Unmarried / Divorced / Widowed / Missing 0.008 1.08 1.02, 1.14
Family status: Married versus any other status 0.01 0.83 0.72, 0.96
Family type: Joint (three generations) / nuclear (two generations) / single /
family of 2 people
0.20
Religion: Muslim / Christian / Other 0.17
Religion: Muslim / any other religion 0.07 1.12 0.99, 1.28
Ethnicity: Russian / any other ethnicity 0.16
Body height (cm) 0.13
Body weight (kg) < 0.001 0.99 0.98, 0.99
Body mass index (kg/m2) < 0.001 0.97 0.96, 0.98
Waist circumference (cm) < 0.001 0.99 0.98, 0.99
Hip circumference cm) 0.001 0.99 0.99, 0.997
Waist-Hip-Ratio < 0.001 0.18 0.08, 0.38
Socioeconomic parameters
Level of education 0.11
Monthly Income (Below poverty line / average / above average / high) 0.04 0.88 0.77, 0.99
Own ownership of house (yes / no) 0.08 0.87 0.74, 1.02
Own ownership of refrigerator (yes / no) 0.10 0.45 0.18, 1.15
Own ownership of second house (yes / no) 0.007 0.72 0.58, 0.91
Own ownership of telephone (yes / no) 0.79
Own ownership of smartphone (yes / no) 0.39
Own ownership of television set (yes / no) 0.60
Own ownership of car (yes / no) 0.001 0.72 0.60, 0.87
Own ownership of two-wheeler (yes / no) 0.66
Own ownership of tractor (yes / no) 0.10 1.47 0.93, 2.31
Own ownership of bullock cart (yes / no) 0.62
Own ownership of computer (yes / no) < 0.001 0.71 0.59, 0.86
Physical activity
How long is your usual work day? (Minutes) 0.79
Does your work involve mostly sitting or standing with less than 10 min
of walking at a time? (Yes / No)
0.97
Does your work involve physically vigorous activity (like heavy lifting or
digging) or physically moderate intensity activity (like brisk walking or
carrying light loads) (Yes / No)
0.38
How many days a week do you do such physically vigorous activity
during work? (Yes / No)
0.67
On a usual day how much time do you spend on such physically
vigorous work during work? (Minutes)
0.96
Does your work involve physically moderate-intensive activity, like
brisk walking or carrying light loads for at least 10 min at a time?
0.96
In a typical week, on how many days do you do physically moderate
to intensive activities as part of your work?
0.10
Per mean day including all days of the week, how much time do
you spend with physically moderate to intensive activities as part of your work?
0.59
Do you walk or use a bicycle (pedal cycle) for at least 10 min continuously
to get to and from places?
0.52
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Table 2 Associations of the prevalence of anemia (defined as a hemoglobin concentration < 140 g/ in men and < 130 g/L in
women) in the Ural Eye and Medical Study, after adjusting for gender and age (Continued)
Parameter P-Value Odds Ratio 95% Confidence Intervals
In a typical week, on how many days do you walk or bicycle for at least
10 min to go to and from places?
0.44
How much time do you spend walking or bicycling for travel in a day? 0.54
Does your recreation, sport or leisure time involve mostly sitting, reclining
or standing activities, with no physical activity lasting more than 10 min at a time?
0.53
In your leisure time, do you do any physically vigorous activities like running,
strenuous sports or weight lifting for at least 10 min at a time?
0.52
If yes, In a typical week, on how many days do you do physically vigorous
activities as part of your leisure time?
0.62
How much time do you spend on physically vigorous activities as part of
your leisure time on a typical day?
0.28
In your leisure time, do you do any moderate intensity activities like
brisk walking, cycling or swimming for at least 10 min at a time?
0.97
In a typical week, on how many days do you do physically moderate
to intensive activities as part of your leisure time?
0.76
How much time do you spend on physically moderate to intensive
activities per day of week during your leisure time? (Minutes)
0.63
Over the past 7 days, how much time did you spend sitting or
reclining on a typical day?
0.15
History of diseases
History of arterial hypertension 0.002 0.81 0.71, 0.93
History of arthritis 0.11
History of low back pain 0.11
History of thoracic spine pain 0.34
History of neck pain 0.94
History of headache 0.53
History of therapy of hyperlipidemia 0.55
History of cancer 0.94
History of cardiovascular disorders including stroke 0.91
History of dementia 0.67
History of diabetes mellitus 0.88
History of diarrhea 0.35
History of bone fracture 0.18
History of heart attack 0.33
History of iron-deficiency anemia < 0.001 3.22 2.53, 4.10
History of low blood pressure and hospital admittance 0.12
History of osteoarthritis 0.65
History of skin disease 0.18
History of use of steroids 0.55
History of thyreopathy 0.56
History of tumbling 0.08 0.87 0.74, 1.02
History of unconsciousness 0.42
Age of the last menstrual bleeding (years) 0.92
Age of last regular menstrual bleeding (years) 0.67
History of menopause < 0.001 0.48 0.38, 0.62
Blood concentrations (mmol/L) of:
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Table 2 Associations of the prevalence of anemia (defined as a hemoglobin concentration < 140 g/ in men and < 130 g/L in
women) in the Ural Eye and Medical Study, after adjusting for gender and age (Continued)
Parameter P-Value Odds Ratio 95% Confidence Intervals
Alanine aminotransferase (IU/L) 0.003 0.99 0.99, 0.997
Aspartate aminotransferase (IU/L) 0.02 0.99 0.99, 0.999
Bilirubin, total (μmol/L) < 0.001 0.99 0.99
High-density lipoproteins (mmol/L) 0.88
Low-density lipoproteins (mmol/L) 0.02 0.94 0.89, 0.99
Triglycerides (mmol/L) < 0.001 0.80 0.72, 0.88
Cholesterol (mmol/L) < 0.001 0.91 0.88, 0.95
C-reactive protein (mg/L) 0.46
Rheumatoid factor (IU/mL) 0.001 1.10 1.04, 1.17
Erythrocyte sedimentation rate (mm / hour) < 0.001 1.07 1.06, 1.08
Glucose (mmol/L) 0.28
Creatinine (μmol/L) 0.001 1.004 1.002, 1.007
Urea (mmol/L) 0.001 1.08 1.03, 1.12
Residual nitrogen (g/L) 0.09 2.06 0.89, 4.76
Total protein (g/L) 0.004 0.99 0.98, 0.996
International normalized ratio (INR) 0.09 1.44 0.95, 2.19
Blood clotting time (minutes) < 0.001 9.35 7.90, 11.1
Prothrombin time (%) 0.05 0.99 0.99, 1.00
Erythrocytes (106 cells / μL) < 0.001 0.000 0.000, 0.001
Leukocytes (109 cells / L) < 0.001 0.89 0.86, 0.94
Rod-core granulocyte (% of leukocytes) < 0.001 1.45 1.39, 1.51
Segment nuclear granulocyte (% of leukocytes) < 0.001 0.95 0.94, 0.95
Eosinophil granulocytes (% of leukocytes) < 0.001 1.22 1.14, 1.29
Lymphocytes (% of leukocytes) < 0.001 1.02 1.02, 1.03
Monocytes (% of leukocytes) < 0.001 1.05 1.03, 1.08
Blood pressure, systolic (mmHg) 0.01 0.996 0.993, 0.999
Blood pressure, diastolic (mmHg) < 0.001 0.98 0.98, 0.99
Blood pressure, mean (mmHg) 0.003 0.99 0.98, 0.996
Ankle-brachial index, right side 0.17
Ankle-brachial index, left side 0.07 1.51 0.97, 2.22
Medical Doctor seen within the last year 0.91
Diet
Vegetarian diet / mixed diet 0.74
Number of meals per day 0.51
In a week how many days do you eat fruits? 0.46
How many servings of fruit do you take on one of those days (g) 0.77
In a week how many days do you eat vegetables? 0.35
How many servings of vegetables do you eat on one of those days (gram)? 0.52
Type of oil used for cooking: vegetable oil / non-vegetable oil 0.63
Food containing whole grains (Yes / No) 0.52
Salt consumed per day (g) 0.71
Degree of processing of meat (weak / medium / well done) 0.47
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Table 2 Associations of the prevalence of anemia (defined as a hemoglobin concentration < 140 g/ in men and < 130 g/L in
women) in the Ural Eye and Medical Study, after adjusting for gender and age (Continued)
Parameter P-Value Odds Ratio 95% Confidence Intervals
Smoking
Do you currently smoke any tobacco products? (yes) 0.39
Do you smoke daily? (yes / no) 0.40
How old were you when you first started smoking? (years) 0.95
Have you stopped smoking? (yes / no) 0.81
How many cigarettes do smoke each day? (0 / ≤10 / 11–20 / 21–30 / > 30) 0.55
Package years (package = 20 cigarettes) 0.51
Do you use smokeless tobacco (snuff, chewing tobacco)? 0.99
If yes, daily? (yes / no) 0.66
How much time after awakening do you smoke the first cigarette
of the day? (< 5 min / 6–30 min. / 31–60min. / > 60 min.)
0.009 0.76 0.62, 0.93
Difficult to refrain from smoking in forbidden places? (yes / no) 0.99
Do you smoke more frequently during the first hours after waking
than during the rest of the day? (yes / no)
0.93
Do you smoke when you ill? (yes / no) 0.34
Alcohol
Alcohol consumed such as beer, whisky, rum, gin brandy or
other local products? (yes / no)
0.13
Age when you first started to drink alcohol? 0.24
Did you stop drinking alcohol and are you still completely abstinent? 0.87
Age when you stopped drinking alcohol? 0.82
How many alcoholic drinks do you have on a typical day when you are drinking) 0.52
How often do you have 6 or more drinks on one occasion? (never /
rarely / sometimes / often / cannot say)
0.49
How often during the last year have you found that you were not
able to stop drinking once you had started? (never / rarely / sometimes / often / cannot say)
0.003 1.63 1.19, 2.25
How often during the last year have you failed to do what was
normally expected from you because of drinking? (never / rarely /
sometimes / often / cannot say)
0.02 1.55 1.08, 2.24
How often during the last year have you needed a first drink in the
morning to get yourself going after a heavy drinking? (never / rarely /
sometimes / often / cannot say)
0.16
How often during the last year have you had a feeling of guilt or
remorse after drinking? (never / rarely / sometimes / often / cannot say)
0.01 1.45 1.10, 1.92
How often during the last year have you been unable to remember what
happened the last night? (never / rarely / sometimes / often / cannot say)
0.26
Have you or someone else has been injured as a result of your drinking? 0.19
Has a relative, friend or a doctor or another health worker been concerned
about your drinking or suggested you to drink less?
0.22
Hearing loss
Do you experience the hearing loss (no / sometimes / yes) 0.002 1.06 1.02, 1.10
Does a hearing problem cause you to feel embarrassed when meeting new
people? (no / sometimes / yes)
0.02 1.06 1.01, 1.12
Does a hearing problem cause you to feel frustrated when talking to members
of your family? (no / sometimes / yes)
0.07 1.05 1.00, 1.10
Do you have difficulties in hearing when someone speaks in a whisper tone?
(no / sometimes / yes)
0.04 1.05 1.002, 1.10
Do you feel handicapped by a hearing problem? (no / sometimes / yes) 0.07 1.06 0.996, 1.12
Does a hearing problem cause you difficulties when visiting friends, relatives, 0.09 1.05 0.99, 1.11
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Table 2 Associations of the prevalence of anemia (defined as a hemoglobin concentration < 140 g/ in men and < 130 g/L in
women) in the Ural Eye and Medical Study, after adjusting for gender and age (Continued)
Parameter P-Value Odds Ratio 95% Confidence Intervals
or neighbors?
Does a hearing problem cause you to attend religious services less often than
you would like?
0.04 1.07 1.003, 1.14
Does a hearing problem cause you to have arguments with family members? 0.29
Does a hearing problem cause you to have difficulties when listening to TV or radio? 0.08 1.05 1.00, 1.10
Do you feel any difficulty with your hearing limits hampering your personal or social life? 0.04 1.07 1.003, 1.13
Does a hearing problem cause you difficulties when in a restaurant with relatives or friends? 0.04 1.07 1.003, 1.14
Hearing Loss Total Score 0.02 1.01 1.001, 1.01
Webers test (> right eye / > left eye / equal) 0.02 0.80 0.67, 0.96
Rinne test right ear (positive) 0.62
Rinne test left ear (positive) 0.56
Depression
I was bothered by things that usually don’t bother me. 0.22
I did not feel like eating, my appetite was poor 0.045 1.15 1.003, 1.31
I felt that I could not shake off the blues, even with the help from family and friends 0.61
I felt that I was just as good as other people 0.18
I had trouble keeping my mind on what I was doing 0.28
I felt depressed 0.91
I felt that everything I did was an effort 0.41
I felt hopeful about the future 0.36
I thought my life had been a failure 0.80
I felt fearful 0.49
My sleep was restless 0.18
I was happy 0.52
I talked less than usual 0.22
I felt lonely 0.75
People were unfriendly 0.05 1.17 1.00, 1.36
I enjoyed life 0.45
I had crying spells 0.24
I felt sad 0.97
I felt that people dislike me 0.92
I could not get “going” 0.06 1.15 0.9971.33
Depression score (adapted) 0.46
State-Trait Anxiety Inventory (STAI)
I feel pleasant 0.40
I tire quickly 0.85
I feel like crying 0.35
I wish I could be as happy as others seem to be 0.91
I am losing out on things because I can’t make up my mind soon enough 0.04 1.16 1.01, 1.34
I feel rested 0.20
I am calm, cool and collected 0.83
I feel that difficulties are piling up so that I can’t overcome them 0.09 1.13 0.98, 1.30
I worry too much over something that really doesn’t matter 0.33
I am happy 0.96
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significantly, with a lower waist-hip circumference ratio
(P = 0.058) (Table 6). In women, it was significantly
higher before menopause (8.8%; 95%CI: 6.4, 11.1) than
after menopause (3.5%; 95%CI: 2.8, 4.3).
In multivariable linear regression analysis, the blood
hemoglobin concentration was associated (regression
coefficient r2 = 0.50) with male gender (P < 0.001), lower
waist-hip circumference ratio (P < 0.001), lower preva-
lence of an ownership of a car (P < 0.001), lower blood
concentrations of bilirubin (P < 0.001) and triglycerides
(P < 0.001), higher erythrocyte sedimentation rate (P <
0.001) and longer blood clotting time (P < 0.001)
Table 2 Associations of the prevalence of anemia (defined as a hemoglobin concentration < 140 g/ in men and < 130 g/L in
women) in the Ural Eye and Medical Study, after adjusting for gender and age (Continued)
Parameter P-Value Odds Ratio 95% Confidence Intervals
I am inclined to take things hard 0.30
I lack self-confidence 0.77
I feel safe 0.43
I try to avoid facing a crises or difficulty 0.23
I feel blue 0.20
I am content 0.26
Some unimportant thoughts run through my mind and bother me 0.11
I take disappointments so keenly that I can’t put them out of my mind 0.83
I am a steady person 0.68
I get in a state of tension or turmoil as I think over my recent concerns and interests 0.42
State-Trait Anxiety Inventory (STAI) Score (adapted) 0.73
I attempted suicide due to financial reasons then 0.51
Have you thought of committing suicide in the last 6 months or earlier? 0.46
I thоught of suicide 0.31
I thоught of suicide due to financial reasons then 0.67
Dynamometry
Manual dynamometry, right hand (dekaNewton) < 0.001 0.98 0.97, 0.99
Manual dynamometry, left hand (dekaNewton) < 0.001 0.98 0.97, 0.99
Fig. 2 Graph showing the prevalence of anemia stratified by age and gender in the Ural Eye and Medical Study
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(Table 7). If the parameter of car ownership was re-
placed by the parameter of level of education, higher
educational level was significantly associated with higher
hemoglobin concentration (P = 0.007; beta: 0.03).
Similar results were obtained if the parameters of
erythrocyte sedimentation rate and blood clotting time
as factors secondary to anemia were dropped from the
model,
Discussion
In our population-based study in Russia, higher
hemoglobin concentration was associated with male
gender, higher waist-hip circumference ratio, higher level
of education, higher blood concentrations of bilirubin
and triglycerides, lower erythrocyte sedimentation rate
and shorter blood clotting time. The prevalence of
anemia defined by a hemoglobin concentration < 140 g/L
in men and < 130 g/L in women was 23.6% (95% CI:
22.5, 24.7), and the prevalence of anemia defined by a
hemoglobin concentration of < 130 g/L in men and <
120 g/L in women was 7.7% (95%CI: 7.0, 8.4). The preva-
lence of moderate anemia (hemoglobin concentration:
110 g/L to 80 g/L) was 2.8% (95%CI: 2.4, 3.2) and in-
creased with younger age, female gender, higher erythro-
cyte sedimentation rate, longer blood clotting time, and
marginally significantly, with a lower waist-hip
circumference ratio. In women, it was significantly (P <
0.001) higher before menopause (8.8%; 95%CI: 6.4, 11.1)
than after menopause (3.5%; 95%CI: 2.8,4.3) (Fig. 2).
These prevalence figures for this study population in
Russia were relatively low as compared with other popu-
lations. As in other populations, the prevalence of
anemia was strongly associated with menopause, and to
a minor degree, with a decreased lower waist-hip cir-
cumference ratio and lower socio-economic and educa-
tional background. There was a tendency for a higher
anemia prevalence in the urban region of habitation
(P = 0.10).
Anemia as a major public health problem has been ad-
dressed in numerous studies before, estimating the total
number of individuals affected by anemia to be 1.62 bil-
lion people globally [10]. The prevalence of anemia
ranged between 9% in high-income countries and 43%
in countries with a relatively low degree of development
[10]. Anemia prevalence was usually higher in pregnant
women, women of reproductive age and in children than
in men or elderly women. Global estimates for the
prevalence of anemia were as high as 47% for children
with an age of less than 5 years, 42% for pregnant
women, and 30% for non-pregnant women with an age
of 15 to 49 years [10]. Africa and Asia were the conti-
nents bearing the load of about 85% of the absolute
Table 3 Associations (multivariate analysis) of the prevalence of anemia (defined as a hemoglobin concentration < 140 g/ in men
and < 130 g/L in women) in the Ural Eye and Medical Study
Parameter P-Value Odds Ratio 95% Confidence Interval
Sex (Men / Women) < 0.001 0.52 0.41, 0.65
Waist-Hip Circumference Ratio 0.002 0.16 0.05, 0.51
Ownership of car 0.005 0.74 0.61, 0.92
Blood Concentration of Bilirubin (μmol/L) < 0.001 0.98 0.97, 0.99
Blood Concentration of Triglycerides (mmol/L) 0.003 0.77 0.65, 0.91
Erythrocyte Sedimentation Rate (mm / hour) < 0.001 1.07 1.06, 1.08
Blood Clotting Time (min) < 0.001 8.65 6.68, 11.2
Leukoycte Count (109 cells/L) 0.03 0.93 0.87, 0.99
Table 4 Associations (multivariate analysis) of the prevalence of any anemia (defined as a hemoglobin concentration < 130 g/ in
men and < 120 g/L in women) in the Ural Eye and Medical Study
Parameter P-Value Odds Ratio 95% Confidence Interval
Age (Years) 0.045 0.98 0.97, 1.00
Sex (Men / Women) < 0.001 0.43 0.30, 0.60
Waist-Hip Circumference Ratio 0.01 0.10 0.02, 0.63
Ownership of car 0.006 0.63 0.45, 0.88
Blood Concentration of Bilirubin (μmol/L) 0.006 0.97 0.96, 0.99
Erythrocyte Sedimentation Rate (mm / hour) < 0.001 1.08 1.07, 1.10
Blood Clotting Time (min) < 0.001 6.99 4.76, 10.3
Leukoycte Count (109 cells/L) 0.002 0.84 0.76, 0.94
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anemia burden in the high-risk groups. It has been esti-
mated that globally and per year, anemia contributed to
more than 591,000 perinatal deaths and 115,000 mater-
nal deaths [11]. The figures found for our study popula-
tion from Russia show that the prevalence of anemia in
Russia is similar to the anemia prevalence found in high-
income countries, despite the marked difference between
Russia and high-income countries in the social develop-
ment index (SDI) as calculated by the Global Burden of
Disease Study [8–25]. Using the WHO definition of
anemia, the prevalence of anemia in our study popula-
tion was 7.7% (95%CI: 7.0, 8.4). Correspondingly, none
of the study participants had a severe anemia defined by
a hemoglobin concentration of less than 80mg/L. These
results are in contrast to anemia prevalences found in
countries with a similar SDI as Russia but which show a
markedly higher anemia prevalence including severe
anemia [10, 11, 13–25]. It suggests that the public health
care system in Russia is better than it would be expected
based on its SDI. It agrees with the finding of a relatively
low unawareness rate for diabetes of 25% in the Russian
population (Ural Eye and Medical Study; own data), a
figure similar or even lower than the rate found in high-
income countries.
The results obtained in our study on associations of
anemia with other systemic parameters are in agreement
with findings obtained in previous investigations. The
main factor associated with anemia was female gender
in the reproductive age (Fig. 2), in addition to a low
waist-hip circumference ratio or low body mass index
and a low socio-economic and educational background
[1–3, 10, 11, 13–25].
The univariate analysis included many diverse parame-
ters which were either the determinants of anemia or
the sequels of anemia. Subsequently, the multivariate
analysis consisted of causes and of consequences of
anemia. To cite examples, the parameters of male gen-
der, higher waist-hip circumference ratio, higher preva-
lence of car ownership and status before menopause
were likely variables associated with the causation of
anemia, while the variable of a higher blood concentra-
tion of bilirubin was probably a consequence of anemia.
The diverse nature of the independent parameters in the
multivariable analysis should therefore be taken into ac-
count when the results of the statistical analysis are
discussed.
When the results of our study are discussed, its limita-
tions should be taken into account. First, as for any
population-based study, the participation rate is critical
to assure the representativeness of the study population.
With more than 80% of the eligible population taking
part in our investigation, a pronounced bias in the inclu-
sion of participants might have been unlikely. Second,
our study population was composed of various ethnici-
ties. While this multi-ethnic composition was typical for
Southern Russia, the population of North-Western
Table 5 Associations (multivariate analysis) of the prevalence of moderate anemia (defined as a hemoglobin concentration < 110 g/
L and > 80 g/L) in the Ural Eye and Medical Study
Parameter P-Value Odds Ratio 95% Confidence Interval
Age (Years) 0.008 0.98 0.96, 0.99
Sex (Men / Women) 0.001 2.52 1.47, 4.33
Waist-Hip Circumference Ratio 0.058 0.13 0.02, 1.07
Erythrocyte Sedimentation Rate (mm / hour) < 0.001 1.08 1.06, 1.09
Blood Clotting Time (min) < 0.001 8.56 5.68, 12.9
Table 6 Multivariate linear regression analysis of associations of the blood hemoglobin concentration in the Ural Eye and Medical
Study
Parameter P-Value Standardized Regression
Coefficient beta
Non-Standardized Regression
Coefficient B
95% Confidence Interval
Sex (Men / Women) < 0.001 −0.20 −5.92 −6.75, − 5.09
Waist-Hip Circumference Ratio < 0.001 0.05 8.25 4.08, 12.4
Ownership of Car < 0.001 0.05 1.57 0.78, 2.37
Blood Concentration of Bilirubin
(μmol/L)
< 0.001 0.05 0.07 0.04, 0.10
Blood Concentration
ofTriglycerides (mmol/L)
< 0.001 0.06 1.29 0.76, 1.82
Erythrocyte Sedimentation
Rate (mm / hour)
< 0.001 −0.32 −0.41 −0.45, − 0.38
Blood Clotting Time (min) < 0.001 −0.39 −10.9 −11.6, −10.2
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Russia and Central Russia usually shows a higher per-
centage of Russians. To overcome this potential limita-
tion of our study, we assessed the prevalence of anemia
in dependence of the ethnic background and found that
the prevalence did not differ significantly between the
Russian group and the non-Russian group. The age and
gender distribution in our study population was compar-
able to the results of the Russian census 2010 [12].
Third, there were several definitions of anemia, and we
used the anemia definition based on the blood
hemoglobin concentration. It lacks, however, specificity
for establishing the iron status. Measurement of the con-
centrations of serum ferritin and transferrin receptor in
combination with determinations of the hemoglobin
concentrations would have been better measures.
Fourth, in the statistical analysis we did not clearly dif-
ferentiate between biomarkers which were probably due
to anemia and determinants of anemia.
Conclusions
In conclusion, in this ethically mixed urban and rural
Russian population aged 40+ years, the prevalence of
anemia (defined by a hemoglobin concentration of <
130 g/L in men and of < 120 g/L in women) was rela-
tively low (7.7%;95%CI:7.0,8.4), and it was similar to the
anemia prevalence in high-income countries. As in other
populations, the anemia prevalence was strongly associ-
ated with menopause, and to a minor degree, with a
lower waist-hip circumference ratio and lower socio-
economic and educational background. There was a ten-
dency for a higher anemia prevalence in the urban re-
gion of habitation (P = 0.10). These data may be of
interest for assessing the burden of anemia in Russia.
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